GX CG5 Pill - yellow capsule/oblong, 11mm
Generic Name: lamivudine
Pill with imprint GX CG5 is Yellow, Capsule/Oblong and has been identified as Epivir HBV 100 mg. It is supplied by GlaxoSmithKline.
Epivir-HBV is used in the treatment of Hepatitis B; HIV Infection; Nonoccupational Exposure; Occupational Exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Epivir-HBV 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GX CG5
Epivir HBV
- Generic Name
- lamivudine
- Imprint
- GX CG5
- Strength
- 100 mg
- Color
- Yellow
- Size
- 11.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- GlaxoSmithKline
- Inactive Ingredients
-
hypromelloses,
polyethylene glycol,
magnesium stearate,
microcrystalline cellulose,
polysorbate 80,
ferric oxide red,
sodium starch glycolate type A potato,
titanium dioxide,
ferric oxide yellow
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00173-0662 (Discontinued) | GlaxoSmithKline |
| 66993-0478 | Prasco Laboratories |
Related images for "GX CG5"
More about Epivir-HBV (lamivudine)
- Check interactions
- Compare alternatives
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
- Breastfeeding
Patient resources
Professional resources
Other formulations
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.